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Abstract
Purpose: Tobacco 21 (T21) is a population-based strategy to prevent tobacco initiation. A 
majority of U.S. youths support T21; however, the extent to which individual, interpersonal, and 
community factors influence T21 support is uncertain. This study explored predictors of T21 
support among U.S. youth.
Methods: We analyzed data from the 2015 National Youth Tobacco Survey (n = 17,683) to 
assess the association of peer influence and access to tobacco products on T21 support. We used 
multivariable logistic regression to calculate adjusted odds ratios (aORs) with 95% confidence 
intervals for T21 support. For tobacco nonusers, the model included peer influence along with 
covariates including sex, age, race/ethnicity, household tobacco use, and perceived harm. For 
tobacco users, the model included tobacco access sources (direct purchase, social sources, and 
other means), the aforementioned covariates, and tobacco product type.
Results: Among nonusers, students least receptive to peer influence (aOR = 2.5), those youngest 
in age (11e14 years, aOR = 2.3), and those who believe tobacco is dangerous (aOR = 2.5) had 
higher odds of T21 support. Among users, lower odds of T21 support were observed among those 
who purchased tobacco (aOR = .3) and accessed tobacco through social sources (aOR = .7) or 
other means (aOR = .6) in the past 30 days. Younger tobacco users (11–14 years, aOR = 2.2), 
black, non-Hispanic users (aOR = 3.8), e-cigarette users (aOR = 2.5), and users who believe that 
tobacco is dangerous (aOR = 2.8) had higher odds of T21 support.
Conclusions: Low receptivity to peer influence and lack of access to tobacco products are 
associated with T21 support. Results underscore that T21 implementation may require a social-
ecological approach.
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Preventing tobacco product use among young people is critical, given that nearly 90% of 
daily adult cigarette smokers first try cigarettes by 18 years of age, with 99% first trying 
cigarettes by age 26 [1]. Marked declines in cigarette smoking have occurred over the past 
several decades; however, the tobacco product landscape has evolved in recent years to 
include a diversity of combustible, noncombustible, and electronic products, many of which 
are used by young people. In 2015, 2 in 10 young adults (aged 18–24 years), representing 
51.8 million people, used a tobacco product “every day” or “some days,” with most using a 
combustible product [2]. During 2017, 5.6% of middle school students and 19.6% of high 
school students, representing approximately 3.6 million students, reported current (past 30 
day) tobacco use with 1.7 million using two or more tobacco products [3]. Overall, current 
use of any tobacco product declined during 2011–2017 among middle and high school 
students. Whereas use of cigarettes, cigars, and smokeless tobacco decreased during this 
period, use of e-cigarettes increased among both middle and high school students [3].
Youth use of tobacco products in any form is unsafe, irrespective of whether it is 
combustible, noncombustible, or electronic [1,4,5]. Tobacco products typically contain 
nicotine, which is highly addictive and can harm the developing adolescent brain [6]. Young 
smokers who smoke daily have the risk of becoming more intense smokers and being unable 
to quit, as they may lack the cognitive, environmental, and emotional resources necessary for 
cessation [7]. Preventing tobacco use initiation is further complicated by marketing 
strategies that target youth [1] and frequent exposure to pro-tobacco messages through 
advertising, media, and film [1,8]. A myriad of cognitive, physical, and psychosocial 
changes during adolescence and young adulthood can also result in increased vulnerability 
to tobacco use [1,7].
Numerous evidence-based strategies are effective in preventing tobacco product use among 
young people [1]. Mass media educational campaigns, pricing strategies, advertising 
restrictions, smoke-free policies in worksites and public spaces, smoke-free home rules, and 
product access restrictions comprise a comprehensive set of population-based approaches 
[1]. Increasing the minimum legal age of sale from 18 years to 21 years (tobacco 21 [T21]) 
is a more recent strategy [7,9], first implemented in Needham, MA in 2005. As of August 
2018, six states (Hawaii, California, Oregon, New Jersey, Maine, and Massachusetts), the 
District of Columbia, two U.S. territories (Guam, Palau) [10], and over 330 cities and 
counties in 21 states have passed T21 legislation.
The potential public health benefits of T21 were recently summarized in an Institute of 
Medicine report, including estimated reduced or delayed tobacco use initiation; lowered 
tobacco use prevalence among youth and adults; and reduced risk for tobacco-related 
morbidity and mortality [7]. More specifically, it is estimated that, for the 2010–2019 birth 
cohort, nationwide T21 would avert 250,000 premature deaths, 45,000 deaths caused by 
lung cancer, and 4.2 million years of life lost [7]. The estimated impact of nationwide T21 
extends further to maternal-child outcomes related to smoking during pregnancy and infants’ 
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exposure to secondhand smoke. Under a T21 assumption, modeling studies project 486,000 
fewer cases of low birth weight and 4,000 fewer cases of sudden infant death syndrome by 
2100 [7]. While population-based research regarding the effectiveness of statewide T21 
policies is limited due to their recent emergence, findings from simulation models [11–13], 
research in specific communities [14] and other countries [15], and initial evaluation results 
of nascent policies [16] demonstrate T21’s remarkable potential for impact.
By expanding the legal definition of “underage,” T21 policies work directly by restricting 
more youths’ access to tobacco products in retail settings, commonly enacting penalties for 
vendors and, in some cases, consumers and social sources for tobacco. Given that younger 
students often obtain tobacco products from older peers [7] and that many adolescents 
initiate smoking because of the influence of friends who smoke [17], disrupting tobacco 
access patterns is an important benefit of T21 laws. Increasing the minimum legal age of 
sale for tobacco products creates additional social distance as a barrier between adolescents 
and persons of legal purchasing age who will more likely fall outside their social circle [7].
Garnering support for T21 among youth is critical from a behavioral and social norms 
standpoint. Support for tobacco control policies is generally associated with compliance 
among youth [18] and young adults [19]. Moreover, public support leads to policy adoption, 
normalization, and acceleration across populations [4,20]. To gauge public opinion about 
T21 policies, researchers have examined attitudes in the U.S. about T21. Among adults, 
overall support for T21 is estimated to be 66%–75% in 2013–2015 [21–25], including nearly 
two-thirds of current cigarette smokers and more than half of current users of other tobacco 
products [25]. Among youth, national estimates of support for T21 are 64% among middle 
and high school students in 2015 [26] and 80% among youth aged 13–17 years from 2014 to 
2017 [27]; however, research on factors that may influence youth attitudes toward T21 
policies is limited.
Support for T21 may vary by youths’ beliefs about the risks posed by various tobacco 
products, their perceptions and experiences with policy enforcement, and their ability to 
obtain tobacco through social sources whether or not covered by T21. Moreover, attitudes 
about increased age restrictions both reflect and shape tobacco-related social norms, which 
are known to predict individuals’ tobacco use behavior [28]. Examination of variation in 
attitudes about T21 could help identify opportunities for intervention and potential reasons 
for support, opposition, or indifference that are jointly related to tobacco use prevalence. 
Therefore, taking a social-ecological approach, we sought to understand individual, 
interpersonal, and community factors associated with support among youth T21. As 
conceptualized, individual factors include personal characteristics and tobacco-related 
beliefs, and interpersonal factors refer to the social environment, particularly among peers 
and in the home. Community factors encompass aspects of the physical and policy 
environment as they pertain to tobacco access.
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Methods
Data source
The National Youth Tobacco Survey [29] is a nationally representative, cross-sectional 
survey administered annually in U.S. public and private schools using a three-stage cluster 
sample design. In 2015, 17,711 students (63.4% overall response rate) in grades 6–12 
completed a paper-and-pencil questionnaire that, along with demographics, measured 
tobacco use susceptibility, current tobacco use, and tobacco-related knowledge and attitudes, 
among other topics. For the present study, 28 records from 9- and 10-year-olds were dropped 
because of data irregularities (e.g., discrepant age-grade combinations), yielding a final 
sample of 17,683 students aged 11 years and older. The Centers for Disease Control and 
Prevention’s Institutional Review Board approved the National Youth Tobacco Survey data 
collection.
Measures
The dependent variable, support for T21, was assessed by the question: Do you think the 
minimum age to buy tobacco products should be 21? Response options included: definitely 
yes, probably yes, probably not, and definitely not. A dichotomous variable for support of 
T21 was created; respondents who answered definitely yes or probably yes were considered 
to support T21 (vs. probably not or definitely not).
Peer influence (among tobacco nonusers) and access to tobacco (among tobacco users) were 
assessed for associations with support of T21. Receptivity to protobacco peer influence was 
measured for three separate tobacco product types (cigarette; cigar/little cigar/cigarillo; and 
e-cigarette) as follows: If one of your best friends were to offer you a [PRODUCT], would 
you [use/smoke] it? Categorical response options for each question were: “definitely yes,” 
“probably yes,” “probably not,” and “definitely not.” This question has previously been used 
to create the construct of susceptibility (along with two other questions assessing intentions 
to use tobacco “soon” and in the “next year”) [30]. For our analyses, however, we were 
interested in exploring the role of peer receptivity as a social determinant of T21 support, 
consistent with a socio-ecological approach. To assess for dose-response along the gradient 
of receptivity consistent with an established coding convention [30], peer receptivity, taking 
into account all three products assessed, was categorized as non-receptivity (coded as 0; 
responses of “definitely not” on all three questions), low receptivity (coded as 1; “probably 
not” response on at least one question and no response of “definitely yes” or “probably 
yes”), and high receptivity (coded as 2; responses of “definitely yes” or “probably yes” on at 
least one question). Past 30-day access to tobacco products was classified by the source type: 
direct purchase (bought from point-of-sale location themselves); social sources (bought from 
another person, had someone else buy them, asked someone for them, or were offered them 
by someone); and alternate means (taking them or accessing them through some other way 
not already described).
Sociodemographic characteristics (sex, age, and race/ethnicity), as well as two tobacco use–
related covariates, were also assessed. Current use of any tobacco product was measured by 
use on at least one day in the past 30 days: cigarettes; cigars, cigarillos, or little cigars; 
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smokeless tobacco (chewing tobacco, snuff, dip, snus, and/or dissolvable tobacco products); 
electronic cigarettes; bidis; hookah or water pipe; and/or pipe filled with tobacco. Use of 
tobacco products then was grouped into mutually exclusive categories: nonuser (no current 
use of any tobacco product); e-cigarettes only (current use of e-cigarettes but no other 
tobacco product); combustibles only (current use of cigarettes, cigars/little cigars/cigarillos, 
pipe tobacco, hookah, and/or bidis but not e-cigarettes or smokeless tobacco products); 
smokeless tobacco only (current use of chewing tobacco, snuff or dip, dissolvable tobacco 
products, and/or snus but not e-cigarettes or combustible tobacco products); and 
multiproduct use (current use of at least one product in more than one category). In addition, 
household exposure to tobacco use was captured in binary form by the question: Does 
anyone who lives with you now [use any form of tobacco]? Affirmative selections of “no 
one” were coded as 0 for no; otherwise, responses were coded as 1 for yes. Perceived risk of 
tobacco use was measured by a single item: How strongly do you agree with the statement 
“All tobacco products are dangerous”? Response options were strongly agree, agree, 
disagree, and strongly disagree.
Analysis
Data were weighted [29] to account for the complex survey design, adjusted for 
nonresponse, and analyzed using complex survey analysis procedures in SAS, version 9.3 
[31]. We computed overall and stratified prevalence estimates (with 95% confidence 
intervals) for the unadjusted associations of support for T21 by each independent variable 
for both tobacco users and nonusers. Within-group differences were assessed by chi-squared 
tests (alpha = .05). Estimates with a relative standard error <30% were considered 
statistically reliable. We then used multivariable logistic regression to examine associations 
between receptivity to protobacco peer influence (among nonusers) and access to tobacco 
products through direct purchase, social sources, and other means (among users) and T21 
support. For each multivariable logistic regression (i.e., nonusers and users modeled 
separately), we computed adjusted odds ratios (aORs) with 95% confidence intervals that 
controlled for demographic characteristics, perceived risk of tobacco use, and (among users) 
type of tobacco product used. p values <.05 were considered statistically significant.
Results
Overall, a majority of youth younger than 18 years expressed support for T21 (Table 1). 
Younger students aged 11–14 years were more supportive of T21 than older students aged 
15–17 years (72.5 vs. 58.5%, respectively). Less than half (42.9%) of students aged 18 years 
and older supported T21. Greater support for T21 was observed among females (66.5% vs. 
61.8% for males), tobacco nonusers (70.9% vs. 30.3% for users of tobacco in any form [data 
not shown]), and students without a tobacco user in their household (68.4% vs. 57.8% who 
live with a tobacco user). Over two-thirds (68.8%) of students who believed tobacco 
products are dangerous supported T21 compared to 35.1% who held opposite risk 
conceptions.
Among current nonusers, support for T21 varied inversely by receptivity to protobacco peer 
influence. Over three-fourths (76.5%) of nonusers who reported not being receptive to using 
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tobacco products if offered by a friend supported the proposed age restriction. Among 
nonusers with low receptivity, 70.4% supported T21, while 51.9% of those most vulnerable 
to peer influence expressed support.
Among users, support varied by product type used, from 18.8% among multiproduct users to 
49.5% among exclusive users of e-cigarettes. Among users who recently made a direct 
tobacco purchase, 1 in 10 (12.1%) supported T21. Among users who obtained tobacco 
through social sources, 1 in 4 (25.0%) supported T21. Similar support was observed among 
users who reported taking tobacco products or getting them some other way (24.0%).
Among nonusers, adjusted results (Table 2) revealed that the odds of supporting T21 differed 
based on receptivity to peer influence. Compared with highly receptive students, those with 
low or no receptivity had two-fold higher odds (low receptivity, aOR = 1.9; nonreceptivity, 
aOR = 2.5) of supporting T21. In contrast, users who bought tobacco through a direct 
purchase had 70% lower odds (aOR = .3) of supporting T21 (Table 3). Similarly, users who 
reported recently accessing tobacco through social sources or obtaining tobacco products 
through alternate means had 30% (aOR = .7) and 40% (aOR = .6) lower odds, respectively, 
of supporting T21.
Discussion
This study demonstrates that the majority of middle and high school students support T21. 
Given adults’ majority support of T21 [21–25], findings reinforce that T21 favorability spans 
generations. Among tobacco nonusers, the strongest support for T21 was found among 
students with lower receptivity to pro-tobacco peer influence. Among tobacco users, those 
who accessed tobacco products through direct purchase, social sources, or other means (e.g., 
theft) were less supportive of T21 compared with those who did not report accessing tobacco 
in these ways. Exclusive users of e-cigarettes had greater odds of supporting T21 compared 
with users of other types of tobacco products, possibly reflecting confusion about e-
cigarettes’ categorization as a tobacco product [5] and an assumption that e-cigarettes would 
not be included in T21 policies. Those who were younger (i.e., further away from proposed 
age restriction) and those who believed tobacco products are dangerous had greater odds of 
supporting T21. These findings indicate that individual, interpersonal, and community 
factors are associated with T21 support among youth, which could serve as a useful evidence 
base for states and communities considering T21.
The Family Smoking Prevention and Tobacco Control Act of 2009 (“Tobacco Control Act”) 
gave the U.S. Food and Drug Administration (FDA) broad authority over the manufacturing, 
marketing, and sale of tobacco products. This authority granted by the U.S. Congress allows 
FDA, among other regulatory powers, the right to restrict advertising and cigarette and 
smokeless tobacco sales to youth [7]; as of 2016, the FDA’s authority further extends to a 
wider range of tobacco products, including e-cigarettes [5]. The Tobacco Control Act, 
however, prohibits the FDA from setting a national minimum legal age above 18 years for 
selling tobacco products. Importantly, the Tobacco Control Act does not preempt state and 
local efforts with regard to many tobacco prevention and control strategies, including T21. 
Therefore, efforts to increase the minimum legal age above 18 years are left to states and 
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local jurisdictions. Presently, 25% of the U.S. population is covered by a T21 policy at the 
state or local level (http://tobacco21.org).
Under the assumption of a national T21 policy, simulation studies have been conducted to 
estimate the public health implications of an increased minimum legal age for tobacco 
product sales. Over time, tobacco use initiation among adolescents aged 15‒17 years would 
be expected to decline 25% following implementation of a national T21 policy. Researchers 
predicted that, by 2100, smoking prevalence among adults would drop 12% beyond expected 
declines, resulting from current tobacco control policies. Furthermore, 250,000 smoking-
related deaths would be averted, including 36% premature deaths to persons < 65 years of 
age [7]. Absent a uniform minimum legal age of 21 years for tobacco product sales, these 
predicted outcomes depend on collective state and local action to restrict legal access to 
tobacco. In real-world conditions, change will depend on specific T21 policy elements, 
adequate policy implementation and enforcement, and sufficient time for shifts in social 
norms to occur [32,33].
To offer the full scope of public health protection across the numerous types of tobacco 
products being used in the U.S. marketplace, model T21 policies address the diversity of 
tobacco products (specifically including e-cigarettes and other electronic products [9]), 
emphasize penalties and enforcement for under-age sales (not possession), carry no 
exemptions for special populations (e.g., military), and disallow pre-emption of stronger, 
local ordinances [34]. To protect youth and young adults from the harms of nicotine 
addiction, the U.S. Surgeon General outlined a multipronged, evidence-based strategy that 
includes increasing and enforcing minimum age laws for selling tobacco products, including 
e-cigarettes [5]. Given e-cigarettes’ potential to renormalize smoking, and the growing body 
of science suggesting that e-cigarette use among youth may lead to subsequent conventional 
cigarette smoking [35,36], continued examination of attitudes toward T21 by product use is 
warranted. To curtail underage access, enforcement of age restrictions is a critical 
component of T21 laws aimed primarily at the retail environment [7]. Frequently cited best 
practices for implementing T21 include intentional planning of enforcement strategies, 
compliance inspections, effective penalties for violations (including criminal prosecution), 
and merchant education [32].
T21 policies can also help shape societal norms and reinforce the denormalization of 
tobacco use behaviors. At a group or organizational level (e.g., school, sports team), 
compliance with T21 policies (and, otherwise, smoke-free campus policies) may impact 
actual and perceived tobacco use prevalence norms, both of which are associated with 
tobacco product susceptibility and/or use [28,37]. In family systems, parental controls (e.g., 
home punishments) possibly in response to legal and social risks posed by violations of T21 
laws that include penalties for individuals’ possessing, using, and furnishing tobacco to 
under-age persons may further denormalize youth tobacco use [7]. Over time, a decline in 
tobacco prevalence may also be accelerated by younger students’ behavioral modeling of 
their older peers who may increasingly adapt to shifting social norms unfavorable to tobacco 
use [32]. Support for T21 is associated with lower intentions to initiate cigarette smoking 
and increased intentions to quit [26]. Thus, as an indicator of social norms, periodic 
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assessment of youth attitudes toward T21 can be useful to examine associated changes in 
tobacco use susceptibility, initiation, and prevalence.
Our study is subject to some limitations. First, given the study’s cross-sectional design, we 
are unable to ascertain whether factors had a temporal influence on support for T21. Absent 
longitudinal data, we can only detect that certain associations exist. Second, the receptivity 
to protobacco peer influence scale was newly developed for this study; its psycho-metric 
properties are unknown without further validation. Third, because students self-reported 
their attitudes and tobacco use behavior, estimates are subject to response and recall biases; 
however, research supports the validity of self-reporting smoking behavior among youth 
[38]. Finally, the findings might not be generalizable to all youth; those who are home-
schooled, have dropped out of school, or are in detention centers are not included in this 
survey. However, despite these limitations, overall trends are generally similar to other 
nationally representative surveys of tobacco use among youth [39,40].
T21 policies reflect one of the several strategies that comprise a comprehensive approach to 
population-based tobacco prevention and control [5]. As a strategy to reduce tobacco use 
initiation, T21 garners support that spans generations. Results demonstrate that individual, 
interpersonal, and community factors influence support of T21 among youth. For states and 
communities considering T21, results underscore the importance of taking a social-
ecological approach to T21 implementation.
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IMPLICATIONS AND CONTRIBUTION
Tobacco nonusers with less receptivity to peer influence had greater odds of supporting 
tobacco 21 (T21) policies. Tobacco users with recent access to tobacco products through 
direct or social sources had lower odds of supporting T21 policies. These results can 
inform states and communities considering or implementing T21 policies.
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es
s t
ob
ac
co
 o
nl
y 
in
cl
ud
es
 c
ur
re
nt
 u
se
 o
f a
t l
ea
st 
o
n
e 
sm
o
ke
le
ss
 to
ba
cc
o 
pr
od
uc
t b
u
t n
ot
 c
om
bu
st
ib
le
s o
r e
-c
ig
ar
et
te
s.
 M
ul
tip
ro
du
ct
 u
se
 in
cl
ud
es
 th
os
e 
w
ho
 re
po
rte
d 
us
e 
of
 a
t l
ea
st 
on
e 
pr
od
uc
t i
n 
m
or
e 
th
an
 o
ne
 c
at
eg
or
y 
(i.
e.,
 e-
cig
ar
et
te
s,
 c
om
bu
st
ib
le
s, 
sm
o
ke
le
ss
 to
ba
cc
o).
j Re
sp
on
de
nt
s w
er
e 
as
ke
d 
“H
ow
 s
tr
on
gl
y 
do
 y
ou
 a
gr
ee
 w
ith
 th
e 
sta
te
m
en
t ‘
A
ll 
to
ba
cc
o 
pr
od
uc
ts 
ar
e 
da
ng
er
ou
s’
?”
k R
es
po
nd
en
ts 
w
er
e 
as
ke
d 
“D
oe
s a
ny
on
e 
w
ho
 li
v
es
 w
ith
 y
ou
 n
ow
 u
se
 a
n
y 
fo
rm
 o
f t
ob
ac
co
?”
l S
ix
ty
 c
as
es
 w
ith
 d
at
a 
co
nf
lic
ts 
w
er
e 
re
m
ov
ed
 fr
om
 a
na
ly
sis
 (e
.g.
, a
ns
we
red
 “I
 di
d n
ot 
ge
t a
ny
 o
f m
y 
ow
n
 to
ba
cc
o 
pr
od
uc
ts 
in
 th
e 
pa
st 
30
 d
ay
s”
 a
nd
 se
le
ct
ed
 a
t l
ea
st 
on
e 
of
 7
 so
ur
ce
s f
or
 g
et
tin
g 
to
ba
cc
o 
pr
od
uc
ts 
in
 th
e 
sa
m
e 
tim
e 
pe
rio
d).
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Table 2
Favorability toward 21 years as the minimum age to purchase tobacco products among tobacco nonusersa, 
U.S. middle and high school students, aged 11 to 18+, NYTS 2015b
Characteristic aORc,d (95% CI)
Receptivity to protobacco peer influencee
 Non-receptivity 2.5 (2.1, 2.9)
 Low receptivity 1.9 (1.7, 2.3)
 High receptivity 1.0
Sex
 Female 1.1 (1.0, 1.3)
 Male 1.0
Age (years)
 11–14 2.3 (2.0, 2.8)
 15–17 1.8 (1.5, 2.2)
 18+ 1.0
Race/ethnicity
 White, non-Hispanic 1.0
 Black, non-Hispanic .9 (.8, 1.0)
 Hispanic .8 (.7, 1.0)
 Other, non-Hispanic 1.0 (.8, 1.2)
 Multiple races .9 (.7, 1.1)
Perceived tobacco dangerf
 Agree or strongly agree 2.5 (2.2, 2.9)
 Disagree or strongly disagree 1.0
Tobacco product use in householdg
 Yes 1.0
 No 1.2 (1.0, 1.3)
Boldface indicates statistical significance at p < .05.
aOR = adjusted odds ratio; CI = confidence interval; NYTS = National YouthTobacco Survey.
aNonuser includes those who reported no use of any tobacco product within the past 30 days.
b
Favorability is defined as a response of “definitely yes” or “probably yes” to the question: Do you think the minimum age to buy tobacco products 
should be 21?.
c
aOR is obtained using binary logistic regression for survey data, adjusted for covariates listed in the table.
d
Individuals with missing data on the covariates listed in the table were excluded from the analysis, yielding a sample size of 13,242.
e
Receptivity to protobacco peer influence is based on responses to this question for three product types (cigarette, cigar/cigarillo/little cigar, e-
cigarette): “If one of your best friends were to offer you a [PRODUCT] would you [use/smoke] it?” “Definitely not” on all three questions = 
nonreceptivity; “probably not” on at least one question and no “definitely yes” or “probably yes” responses = low receptivity; “definitely yes” or 
“probably yes” on at least one question = high receptivity.
f
among tobacco users, Respondents were asked “How strongly do you agree with the statement ‘All tobacco products are dangerous’?”
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g
Respondents were asked “Does anyone who lives with you now use any form of tobacco?”
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Table 3
Favorability toward 21 years as the minimum age to purchase tobacco products U.S. middle and high school 
students, aged 11 to 18+, NYTS 2015a.
Characteristic aORb,c (95% CI)
Accessed tobacco through direct purchased,g
 Yes .3 (.2, .5)
 No 1.0
Accessed tobacco through social sourcese,g
 Yes .7 (.5, .8)
 No 1.0
Accessed tobacco some other wayf,g
 Yes .6 (.4, .8)
 No 1.0
Sex
 Female 1.1 (.9, 1.4)
 Male 1.0
Age (years)
 11–14 2.2 (1.3, 3.6)
 15–17 1.3 (.8, 1.9)
 18+ 1.0
Race/ethnicity
 White, Non-Hispanic 1.0
 Black, Non-Hispanic 3.8 (2.3, 6.3)
 Hispanic 2.0 (1.6, 2.5)
 Other, Non-Hispanic 1.6 (1.0, 2.6)
 Multiple races 2.1 (1.3, 3.5)
Tobacco product useh
 E-cigarettes only 2.5 (1.9, 3.3)
 Combustibles only 1.2 (.9, 1.6)
 Smokeless tobacco only 1.4 (.9, 2.3)
 Multiproduct use 1.0
Perceived tobacco dangeri
 Agree or strongly agree 2.8 (2.2, 3.6)
 Disagree or strongly disagree 1.0
Tobacco product use in householdj
 Yes 1.0 (.8, 1.1)
 No 1.0
Boldface indicates statistical significance at p < .05. aOR = adjusted odds ratio; CI = confidence interval; NYTS = National YouthTobacco Survey.
a
Favorability is defined as a response of “definitely yes” or “probably yes” to the question: Do you think the minimum age to buy tobacco products 
should be 21?
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b
aOR is obtained using binary logistic regression for survey data, adjusted for covariates listed in the table.
c
Individuals with missing data on the covariates listed in the table were excluded from the analysis, yielding a sample size of 2,676.
d
Having access to tobacco products through direct purchase includes those who reported personally buying tobacco from a point of sale in the past 
30 days.
e
Having access to tobacco products through social sources includes those who reported obtaining tobacco products in the past 30 days through 
either purchasing them from another person, having someone else buy them, asking someone for them, or being offered them by someone.
f
Having access to tobacco products through some other way includes those who reported obtaining tobacco products in the past 30 days by taking 
them or through other means not already listed.
gSixty cases with data conflicts were removed from analysis (e.g., answered “I did not get any of my own tobacco products in the past 30 days” and 
selected at least one of the seven sources for getting tobacco products in the same time period).
hCombustibles include cigarettes, cigars, pipes, hookah, and bidis. Smokeless tobacco includes chewing tobacco, snuff, dip, dissolvables, and snus. 
E-cigarettes only include those who reported current (i.e., in past 30 days) use of e-cigarettes but not any other tobacco product. Combustibles only 
include those who reported current use of at least one combustible product but neither smokeless tobacco nor e-cigarettes. Smokeless tobacco only 
includes current use of at least one smokeless tobacco product but not combustibles or e-cigarettes. Multi-product use includes those who reported 
use of at least one product in more than one category (i.e., e-cigarettes, combustibles, smokeless tobacco).
i
Respondents were asked “How strongly do you agree with the statement ‘All tobacco products are dangerous’?”
j
Respondents were asked “Does anyone who lives with you now use any form of tobacco?”
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